Lori Styles is an Oncology physician. OpenAlex indexes 128 publications with 8,556 citations (h-index 47); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
747 52nd Street
Oakland, CA 94609
Telephone
510-428-3372Registry record last updated 8 Jul 2007.
Clinical trials
- Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
Sponsor: Summit Therapeutics
- Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Sponsor: Summit Therapeutics
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
6 NIH research awards on record, funded 1997–2009 per NIH RePORTER. The latest:
- Arginine as Prophylactic Therapy in Sickle Cell Disease
Children'S Hospital & Res Ctr at Oakland
FY2009$154,621K24HL074256 - Arginine as Prophylactic Therapy in Sickle Cell Disease
Children'S Hospital & Res Ctr at Oakland
FY2008$150,118K24HL074256 - Phospholipase A2 Inhibitor Safety Trial
Children'S Hospital & Res Ctr at Oakland
FY2007$344,536U54HL070583
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study
Journal of Clinical Oncology
2023 - Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study
Biology of Blood and Marrow Transplantation
2019
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”